ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

November 27, 1987

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003